{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# In this notebook, we are qualitatively building categories\n",
    "\n",
    "We look at the file: \\\n",
    "`../data/06-clustered-df/alpha0.3_k10_res0.002.pkl`\n",
    "\n",
    "And the corresponding excel file: \\\n",
    "`..output/tables/cluster-explorer/FinalSelect/SingleSolExplorer_alpha0.3_k10_res0.002.xlsx`\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Trees:\n",
    "\n",
    "- Pharmacology\n",
    "\n",
    "  - Pharmacodynamics\n",
    "    - Mechanism of action\n",
    "    - Other\n",
    "  - Pharmacokinetics\n",
    "  - Pharmacogenetics\n",
    "  - Other\n",
    "\n",
    "- Indications\n",
    "\n",
    "  - Disorders\n",
    "    - Depression\n",
    "    - Anxiety\n",
    "    - OCD\n",
    "    - Other\n",
    "  - Special Popultions\n",
    "  - Other\n",
    "\n",
    "- Safety\n",
    "\n",
    "  - Adverse effects\n",
    "  - Contraindications\n",
    "  - Drug Interactions\n",
    "  - Other\n",
    "\n",
    "- Other\n",
    "  - Drugs\n",
    "  - Ecotoxicology\n",
    "  - Other\n",
    "\n",
    "### Papers will be categorized into the categories above and can reveive the tags:\n",
    "\n",
    "1. Clinical Evidence\n",
    "2. In vivo / In vitro\n",
    "3. Review\n",
    "4. Irrelevant\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# load and prep data\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>eid</th>\n",
       "      <th>title</th>\n",
       "      <th>date</th>\n",
       "      <th>first_author</th>\n",
       "      <th>abstract</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>auth_year</th>\n",
       "      <th>unique_auth_year</th>\n",
       "      <th>pubmed_id</th>\n",
       "      <th>...</th>\n",
       "      <th>reference_eids</th>\n",
       "      <th>nr_references</th>\n",
       "      <th>filtered_reference_eids</th>\n",
       "      <th>nr_filtered_references</th>\n",
       "      <th>title_abstract</th>\n",
       "      <th>clean_title</th>\n",
       "      <th>clean_abstract</th>\n",
       "      <th>specter2_embeddings</th>\n",
       "      <th>cluster_alpha0.3_k10_res0.002</th>\n",
       "      <th>centrality_alpha0.3_k10_res0.002</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2-s2.0-0020316326</td>\n",
       "      <td>Serotonergic mechanism in the control of β-end...</td>\n",
       "      <td>1982-04-12</td>\n",
       "      <td>Bruni J.F.</td>\n",
       "      <td>The role of the serotonergic mechanism in the ...</td>\n",
       "      <td>10.1016/0024-3205(82)90686-5</td>\n",
       "      <td>1982</td>\n",
       "      <td>Bruni_1982</td>\n",
       "      <td>Bruni_1982</td>\n",
       "      <td>6283286.0</td>\n",
       "      <td>...</td>\n",
       "      <td>[2-s2.0-0016795422, 2-s2.0-0000011578, 2-s2.0-...</td>\n",
       "      <td>46</td>\n",
       "      <td>[]</td>\n",
       "      <td>0</td>\n",
       "      <td>Serotonergic mechanism in the control of β-end...</td>\n",
       "      <td>Serotonergic mechanism in the control of β-end...</td>\n",
       "      <td>The role of the serotonergic mechanism in the ...</td>\n",
       "      <td>[-0.38758993, 0.8743463, -0.52714413, 0.029653...</td>\n",
       "      <td>70</td>\n",
       "      <td>0.045627</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2-s2.0-0019936013</td>\n",
       "      <td>EFFECTS OF PAROXETINE ON SYNAPTOSOMAL NEUROTRA...</td>\n",
       "      <td>1982-01-01</td>\n",
       "      <td>Magnussen I.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10.1111/j.1600-0404.1982.tb03382.x</td>\n",
       "      <td>1982</td>\n",
       "      <td>Magnussen_1982</td>\n",
       "      <td>Magnussen_1982_4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>[]</td>\n",
       "      <td>0</td>\n",
       "      <td>[]</td>\n",
       "      <td>0</td>\n",
       "      <td>EFFECTS OF PAROXETINE ON SYNAPTOSOMAL NEUROTRA...</td>\n",
       "      <td>EFFECTS OF PAROXETINE ON SYNAPTOSOMAL NEUROTRA...</td>\n",
       "      <td></td>\n",
       "      <td>[0.329068, 0.23448052, -0.6597941, 0.13635367,...</td>\n",
       "      <td>65</td>\n",
       "      <td>0.010706</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2-s2.0-0020058010</td>\n",
       "      <td>Treatment of intention myoclonus with paroxeti...</td>\n",
       "      <td>1982-01-01</td>\n",
       "      <td>Magnussen I.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1982</td>\n",
       "      <td>Magnussen_1982</td>\n",
       "      <td>Magnussen_1982_3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>[]</td>\n",
       "      <td>0</td>\n",
       "      <td>[]</td>\n",
       "      <td>0</td>\n",
       "      <td>Treatment of intention myoclonus with paroxeti...</td>\n",
       "      <td>Treatment of intention myoclonus with paroxeti...</td>\n",
       "      <td></td>\n",
       "      <td>[0.406605, 1.0992043, -0.60125256, 0.73224956,...</td>\n",
       "      <td>42</td>\n",
       "      <td>0.038800</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3 rows × 38 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                 eid                                              title  \\\n",
       "0  2-s2.0-0020316326  Serotonergic mechanism in the control of β-end...   \n",
       "1  2-s2.0-0019936013  EFFECTS OF PAROXETINE ON SYNAPTOSOMAL NEUROTRA...   \n",
       "2  2-s2.0-0020058010  Treatment of intention myoclonus with paroxeti...   \n",
       "\n",
       "        date  first_author                                           abstract  \\\n",
       "0 1982-04-12    Bruni J.F.  The role of the serotonergic mechanism in the ...   \n",
       "1 1982-01-01  Magnussen I.                                                NaN   \n",
       "2 1982-01-01  Magnussen I.                                                NaN   \n",
       "\n",
       "                                  doi  year       auth_year  unique_auth_year  \\\n",
       "0        10.1016/0024-3205(82)90686-5  1982      Bruni_1982        Bruni_1982   \n",
       "1  10.1111/j.1600-0404.1982.tb03382.x  1982  Magnussen_1982  Magnussen_1982_4   \n",
       "2                                 NaN  1982  Magnussen_1982  Magnussen_1982_3   \n",
       "\n",
       "   pubmed_id  ...                                     reference_eids  \\\n",
       "0  6283286.0  ...  [2-s2.0-0016795422, 2-s2.0-0000011578, 2-s2.0-...   \n",
       "1        NaN  ...                                                 []   \n",
       "2        NaN  ...                                                 []   \n",
       "\n",
       "  nr_references filtered_reference_eids  nr_filtered_references  \\\n",
       "0            46                      []                       0   \n",
       "1             0                      []                       0   \n",
       "2             0                      []                       0   \n",
       "\n",
       "                                      title_abstract  \\\n",
       "0  Serotonergic mechanism in the control of β-end...   \n",
       "1  EFFECTS OF PAROXETINE ON SYNAPTOSOMAL NEUROTRA...   \n",
       "2  Treatment of intention myoclonus with paroxeti...   \n",
       "\n",
       "                                         clean_title  \\\n",
       "0  Serotonergic mechanism in the control of β-end...   \n",
       "1  EFFECTS OF PAROXETINE ON SYNAPTOSOMAL NEUROTRA...   \n",
       "2  Treatment of intention myoclonus with paroxeti...   \n",
       "\n",
       "                                      clean_abstract  \\\n",
       "0  The role of the serotonergic mechanism in the ...   \n",
       "1                                                      \n",
       "2                                                      \n",
       "\n",
       "                                 specter2_embeddings  \\\n",
       "0  [-0.38758993, 0.8743463, -0.52714413, 0.029653...   \n",
       "1  [0.329068, 0.23448052, -0.6597941, 0.13635367,...   \n",
       "2  [0.406605, 1.0992043, -0.60125256, 0.73224956,...   \n",
       "\n",
       "  cluster_alpha0.3_k10_res0.002 centrality_alpha0.3_k10_res0.002  \n",
       "0                            70                         0.045627  \n",
       "1                            65                         0.010706  \n",
       "2                            42                         0.038800  \n",
       "\n",
       "[3 rows x 38 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "params = \"alpha0.3_k10_res0.002\"\n",
    "p = f\"../data/06-clustered-df/{params}.pkl\"\n",
    "df = pd.read_pickle(p)\n",
    "df.head(3)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# helper func\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Cluster 10:\n",
      "Effects of repeated phencyclidine treatment on serotonin transporter in rat brain\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "[<sup>123</sup>I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Measurement of changes in endogenous serotonin level by positron emission tomography with [<sup>18</sup>F]altanserin\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "def cluster_title_print(df,  cluster, random=False, n=10, random_state=1887):\n",
    "    \"\"\"\n",
    "    Print titles of documents belonging to a specific cluster.\n",
    "\n",
    "    Args:\n",
    "    - df: DataFrame containing document data.\n",
    "    - cluster: Cluster number for which titles are to be printed.\n",
    "    - random: Whether to select titles randomly. Defaults to False.\n",
    "    - n: Number of titles to print. Defaults to 10.\n",
    "    - random_state: Seed for random sampling. Defaults to None.\n",
    "\n",
    "    Returns:\n",
    "    - None\n",
    "    \"\"\"\n",
    "    # Filter DataFrame for the specified cluster\n",
    "    cluster_df = df[df[\"cluster_alpha0.3_k10_res0.002\"] == cluster]\n",
    "    \n",
    "    # Sort DataFrame by centrality\n",
    "    cluster_df = cluster_df.sort_values(by=\"centrality_alpha0.3_k10_res0.002\", ascending=False)\n",
    "    \n",
    "    # Select titles\n",
    "    if random:\n",
    "        titles = cluster_df.sample(n, random_state=random_state)['title'].values\n",
    "    else:\n",
    "        titles = cluster_df.head(n)['title'].values\n",
    "    \n",
    "    # Print titles\n",
    "    print(f\"Cluster {cluster}:\")\n",
    "    for title in titles:\n",
    "        print(title)\n",
    "        print(\"# \" * 30)\n",
    "    print(\"\\n\")\n",
    "\n",
    "cluster_title_print(df= df,cluster= 150, random=True, n=3, random_state=None)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Clusters labels are arrived at by assessing the file:\n",
    "\n",
    "`Study-1-Bibliometrics/output/tables/cluster-explorer/FinalSelect/SingleSolExplorer_alpha0.3_k10_res0.002.xlsx`\n",
    "\n",
    "The file contains the 20 most central papers in each cluster as well as 20 random papers from each cluster. 0. What is the defining characteristic of the cluster? (to use as label)\n",
    "\n",
    "1. Does it focus on pharmacology?\n",
    "   - Which area of pharmacology?\n",
    "2. Does it focus on in vivo, vitro, or human?\n",
    "3. Does it focus on a specific disorder?\n",
    "4. Does it focus on a special population?\n",
    "5. Does it focus on a specific drug?\n",
    "6. Does it focus on safety?\n",
    "\n",
    "then it gets one of the following tags.\n",
    "\n",
    "- 1 clinical\n",
    "- 2 in vivo/vitro\n",
    "- 3 mixed\n",
    "- 4 review\n",
    "- 5 garbage\n",
    "- 0 None.\n",
    "\n",
    "The file is manually assessed and the clusters are labeled as follows:\n",
    "\n",
    "A cleaner version in JSON format is saved as `output/cluster-qualifications/K10/ClusterLabels.json`\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "# 1 clinical\n",
    "# 2 in vivo/vitro \n",
    "# 3 Mixed\n",
    "# 4 review\n",
    "# 5 garbage\n",
    "# 0 None.\n",
    "\n",
    "cluster_labels = {\n",
    "    0: [\"Serotonin Receptor Studies\", 2], \n",
    "    1: [\"Aquatic Ecotoxicology\", 0], \n",
    "    2: [\"Prenatal Exposure\",1 ], \n",
    "    3: [\"quantification of SSRIs in biological samples\", 2], \n",
    "    4: [\"Treament of Obsessive-Compulsive Disorder (OCD)\", 1], \n",
    "    5: [\"SSRIs and the Cytochrome P450 System\", 2], \n",
    "    6: [\"Neurogenesis\",2 ], \n",
    "    7: [\"Pediatric Depression\", 1], \n",
    "    8: [\"Herbal and Natural Compounds for Depression, using Forces Swimming Test\", 2], # or forced swimming test? this vs 35. here precl. the other clinical\n",
    "    9: [\"Paroxetine Binding\", 2 ], \n",
    "    10: [\"Neural Processing of Emotional Cues\", 1],\n",
    "    11: [\"Prenatal Exposure\",2],\n",
    "    12: [\"forced swimming test\", 2],\n",
    "    13: [\"serotonin transporter gene and antidepressant response\", 1], # is this clinical? pharmacogenetics..\n",
    "    14: [\"Fluvoxamine for Depression\",2 ],\n",
    "    15: [\"SSRIs for PTSD\", 2 ],\n",
    "    16: [\"Sexual Dysfunction\",1 ],\n",
    "    17: [\"Sequenced Depression Treatment\", 1],\n",
    "    18: [\"Serotonin Syndrome\",1 ],\n",
    "    19: [\"Serotonin and Inflammation\", 3], # this seems like ssri have anti-inflammatory effects but also inflammation can cause depression\n",
    "    20: [\"Post-Stroke SSRI Use\", 1],\n",
    "    21: [\"depression and cardiovascular pathology\",1 ], # quick check pls! its rather depression in this population\n",
    "    22: [\"SSRIs for Pain\",1 ],\n",
    "    23: [\"SSRIs for Bipolar Depression\", 1],\n",
    "    24: [\"SSRI Utilization Patterns\", 1],\n",
    "    25: [\"Escitalopram for Depression\",1 ],\n",
    "    26: [\"SSRIs in Dementias\", 1], # for depression and other symptoms\n",
    "    27: [\"Bleeding Risk\", 1],\n",
    "    28: [\"Serotonin Receptor Studies\", 2], # compare to 0\n",
    "    29: [\"SSRIs for Weight Management\", 1],\n",
    "    30: [\"Suicice Risk\",1 ],\n",
    "    31: [\"Cost-Effectiveness\",0 ], \n",
    "    32: [\"Conditioned Fear\",2 ], \n",
    "    33: [\"Paroxetine\",4,5 ], \n",
    "    34: [\"SSRIs for Panic Disorder\", 1], \n",
    "    35: [\"Herbal and Natural Compounds for Depression\" , 2], \n",
    "    36: [\"Fluvoxamine for Covid 19\", 1 ], \n",
    "    37: [\"SSRIs for Generalized Anxiety Disorder (GAD)\", 1], \n",
    "    38: [\"Fracture Risk\",1 ], \n",
    "    39: [\"Fluoxetine\", 4,5 ], \n",
    "    40: [\"Extrapyramidal Reactions Risk\", 1], # movement disorders\n",
    "    41: [\"SSRIs Effect on Sleep in Depressed Patients\", 1 ], \n",
    "    42: [\"Hot Flushes (Menopause)\", 1], \n",
    "    43: [\"SSRIs for Dermatological Diseases\", 1], # psychodermatology? \n",
    "    44: [\"Oncopreventive and oncolytic properties of SSRIs\",1 ], # mostly risk estimation \n",
    "    45: [\"Premature Ejaculation\",1], \n",
    "    46: [\"QTC Prolongation\", 1], # thats cardiovascular, right?\n",
    "    47: [\"SSRIs for Premenstrual Dysphoric Disorder (PMDD)\",1 ], \n",
    "    48: [\"Depression in Diabetes\", 1], \n",
    "    49: [\"SSRIs for Depression with Cognitive Impairment\",1 ], \n",
    "    50: [\"SSRIs for Eating Disorders\", 1], \n",
    "    51 : [\"SSRIs for Alcohol Dependence\",1 ],\n",
    "    52 : [\"SSRIs for Irritable Bowel Disease\", 1],\n",
    "    53 : [\"Personality Disorder; Learning; Behavioral Effects; introception\", 4], # most central are all borderline personality disorder. random ones are very weird\n",
    "    54: [\"Depression Treatment Review\", 1 , 4 ],\n",
    "    55: [\"Depression in Epileptic Patients\", 1],\n",
    "    56: [\"SSRIs for Autism Spectrum Disorders\",1 ],\n",
    "    57: [\"(Sertraline) Drug Delivery\",2],\n",
    "    58: [\"Depression in Parkinsons Patients\", ],\n",
    "    59: [\"Hepatotoxic Risk\", 2 ], # also check 87 and hepatitis\n",
    "    60: [\"SSRI Synthesis\", 2],\n",
    "    61: [\"SSRIs (Fluvoxamine) for Schizophrenia\",1,],\n",
    "    62: [\"SSRIs for Substance Abuse (Cocaine)\", 2 ],\n",
    "    63: [\"SSRIs for Social Anxiety Disorder\",1,4 ],\n",
    "    64: [\"Sertraline for Depression\",1 ],\n",
    "    65: [\"Drug Drug Interactions\",1 ],\n",
    "    66: [\"Ion Channels\", 2],\n",
    "    67: [\"Methylenedioxymethamphetamine (MDMA) Effects on Serotonin\", 2],\n",
    "    68: [\"Genotype Mediated Response to SSRIs\", 2],\n",
    "    69: [\"Hyponatremia Risk\", 1],\n",
    "    70: [\"Neuroendocrine Effects of Citalopram\", 3],\n",
    "    71: [\"SSRIs for Body Dysmorphic Disorder (BDD)\", 1],\n",
    "    72: [\"Pharmacological Reviews\",2,4 ],\n",
    "    73: [\"Forensic Drug Concentration\", 1],\n",
    "    74: [\"Citalopram for Depression\",1,4 ],\n",
    "    75: [\"SSRIs for Pediatric Anxiety\", ],\n",
    "    76: [\"SSRI Safety Reviews\",1,4 ],\n",
    "    77: [\"Pulmonary Hypertension\", 2],\n",
    "    78: [\"SSRIs as Antifungal Agents\",2 ], # where to put this ? dynamics? disorder? Both?\n",
    "    79: [\"Geriatric Depression\", 1,4],\n",
    "    80: [\"Withdrawal Symptoms\",1 ],\n",
    "    81: [\"Agomelatin for Depression\", 4 ],\n",
    "    82: [\"SSRI Efficacy in Depression\",1,4 ],\n",
    "    83: [\"Wastewater Management\", 0],\n",
    "    84: [\"Astrocyte Receptors\",1 ],\n",
    "    85: [\"Sertraline\", 5],\n",
    "    86: [\"Vilazodone for Depression\",1 ],\n",
    "    87: [\"Depression in Hepatitis Patients\", 1],\n",
    "    88: [\"SSRIs for Depression after Traumatic Brain Injury\", ],\n",
    "    89: [\"SSRIs Effects on Dopamine Receptors\",2 ],\n",
    "    90: [\"Hyperprolactinemia-related Symptoms\", 2], # galactorrhoea; amenorrhea; gynecomastia\n",
    "    91: [\"SSRIs for Fibromyalgia\", 2], # also chronic fatigue syndrome\n",
    "    92: [\"SSRI Use\",5,1 ],\n",
    "    93: [\"SSRIs for Depression in Cancer\", 1],\n",
    "    94: [\"Canine Behavioral Disorders\", 0], # agression in dogs mostly\n",
    "    95: [\"Transcranial Direct Current Stimulation (tDCS) for Depression\", 1],\n",
    "    96: [\"Gatways to Clinical Trials\", 5 ],\n",
    "    97: [\"SRRIs and Ocular Safety\",1 ], # mostly glaucoma\n",
    "    98: [\"Folate for Depression\", 1], # other nutrition topics?\n",
    "    #####################################\n",
    "    ### from here on under 100 papers ###\n",
    "    #####################################\n",
    "    99: [\"Orofacial Pain Disorders\", 3], #bruxism and burning mouth syndrome. treatment and safety -.-\n",
    "    100: [\"SSRIs for Depression in Kidney Disease Patients\", 1], # \n",
    "    101: [\"SSRIs for Enuresis\", 1], # or enuresis or Stress Urinary Incontinence Or Urinary Function?\n",
    "    102: [\"St. John's Wort for Depression\", 1], \n",
    "    103: [\"SSRIs for Migraine\", ], \n",
    "    104: [\"SSRIs for Postpartum Depression\", 1], \n",
    "    105: [\"Behavioral Addictions\",1 ], #  pathological gambling mostly, and problematic internet use\n",
    "    106: [\"Generic SSRIs\", 1], # which category?\n",
    "    107: [\"SSRIs in Model Organisms ( C. Elegans and Drosophilia)\", 2], \n",
    "    108: [\"Differential Reinforcement of Low Rate (DRL) Operant Schedule\", 2], \n",
    "    109: [\"SSRIs for Dysthymia\", 1], \n",
    "    110: [\"SSRIs for Trichotillomania\", 1], \n",
    "    111: [\"Selective serotonin reuptake inhibitors\",5,0 ], \n",
    "    112: [\"Modulation of Serotonin Eelease by Autoreceptors and Heteroreceptors\",2 ], \n",
    "    113: [\"SSRIs and Galanin in Depression\", 2], \n",
    "    114: [\"SSRIs for Huntington Disease\", 1], \n",
    "    115: [\"SSRIs for Depression in and Treatment of Multiple Sclerosis\", 1],  \n",
    "    116: [\"SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients\",1 ], \n",
    "    117: [\"Quantification of Dopamine and Serotonin Release and Uptake\",2 ], \n",
    "    118: [\"Novel Compounds Synthesis and Antidepressant Potential\", 2], \n",
    "    119: [\"Thyroid Hormone for Depression\", 1], \n",
    "    120: [\"Olfactory Bbulbectomized (OB) Rat Model for Depression\", 1], \n",
    "    121: [\"SSRIs for Depression in HIV-positive Patients\", ], \n",
    "    122: [\"SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients\", 1], # may this be a biomarker?\n",
    "    123: [\"Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor\", 3], # for cardiac diseases\n",
    "    124: [\"SSRIs for Smoking Cessation\", 1], \n",
    "    125: [\"Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression\", 2], \n",
    "    126: [\"SSRIs for Syncope\", 1], \n",
    "    127: [\"SSRIs for Tinnitus \",1], \n",
    "    ####################################\n",
    "    ### from here on under 50 papers ###\n",
    "    ####################################\n",
    "    128: [\"Exercise for Depression\", ], \n",
    "    129: [\"SSRIs for Narcolepsy\", 1], \n",
    "    130: [\"Risk of Hallucinations\",1 ], \n",
    "    131: [\"SSRIs for Congenital Myasthenic Syndrome (SCCMS)\", 1], \n",
    "    132: [\"Tryptophan Depletion in Depression\", 1], \n",
    "    133: [\"SSRIs for Tourette's Syndrome\", ], \n",
    "    134: [\"Adulterants in Weight Loss Supplements\", 0], # fluoxetine \n",
    "    135: [\"Risk of Microscopic Colitis\", 1], \n",
    "    136: [\"Critical Psychiatry\", 0], \n",
    "    137: [\"Animal Models of Obsessive-compulsive Disorder (OCD) \", 2], \n",
    "    138: [\"Psychotic Depression (STOP-PD Study)\", 0, 1 ], \n",
    "    139: [\"SSRIs for Pediatric OCD\", ], \n",
    "    ####################################\n",
    "    ### from here on under 25 papers ###\n",
    "    ####################################\n",
    "    140: [\"Treatment of Paroxetine Induced Sexual Dysfunction\",2 ], \n",
    "    141: [\"SSRIs and Bariatric Surgery\", ], #antiobesity surgery\n",
    "    142: [\"Methylphenidate augmentation in late-life depression\", 1],\n",
    "    143: [\"Psilocybin for Depression\",1 ], \n",
    "    144: [\"Risk of Priapism\", 1], #painful erection \n",
    "    145: [\"SSRIs for Depersonalization Disorder\",1 ], \n",
    "    ####################################\n",
    "    ### from here on under 19 papers ###\n",
    "    ####################################\n",
    "    146: [\"Serotonin Modulation Effects on Primates and Rodents\", 2,5],\n",
    "    147: ['Risk of Reversible Rerebral Vasoconstriction Syndrome (RCVS)',1 ],\n",
    "    148: [\"Gateways to Clinical Trials\",5 ], \n",
    "    149: [\"Citalopram Effect on Indoleamine Metabolism in Maturing Mouse Brains\", 2,5], \n",
    "    150: [\"Depressed Infertile Women\", 5], \n",
    "    151: [\"SSRIs for Olfactory reference syndrome (ORS)\", 5], \n",
    "}\n",
    "\n",
    "path = f\"../output/cluster-qualifications/K10/pythonic_cluster_labels_{params}.json\"\n",
    "\n",
    "with open(path, \"w\") as f:\n",
    "    json.dump(cluster_labels, f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "\n",
    "json_string = \"\"\"\n",
    "{\n",
    "    \"0\": { \"label\": \"Serotonin Receptor Studies\", \"evidencetype\": [2] },\n",
    "    \"1\": { \"label\": \"Aquatic Ecotoxicology\", \"evidencetype\": [0] },\n",
    "    \"2\": { \"label\": \"Prenatal Exposure\", \"evidencetype\": [1, 2] },\n",
    "    \"3\": {\n",
    "        \"label\": \"Quantification of SSRIs in Biological Samples\",\n",
    "        \"evidencetype\": [2]\n",
    "    },\n",
    "    \"4\": {\n",
    "        \"label\": \"Treatment of Obsessive-Compulsive Disorder (OCD)\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"5\": { \"label\": \"SSRIs and the Cytochrome P450 System\", \"evidencetype\": [2] },\n",
    "    \"6\": { \"label\": \"Neurogenesis\", \"evidencetype\": [2] },\n",
    "    \"7\": { \"label\": \"Pediatric Depression\", \"evidencetype\": [1] },\n",
    "    \"8\": {\n",
    "        \"label\": \"Herbal and Natural Compounds for Depression, using Forced Swimming Test\",\n",
    "        \"evidencetype\": [2]\n",
    "    },\n",
    "    \"9\": { \"label\": \"Paroxetine Binding\", \"evidencetype\": [2] },\n",
    "    \"10\": { \"label\": \"Neural Processing of Emotional Cues\", \"evidencetype\": [1] },\n",
    "    \"11\": { \"label\": \"Prenatal Exposure\", \"evidencetype\": [2] },\n",
    "    \"12\": { \"label\": \"Forced Swimming Test\", \"evidencetype\": [2] },\n",
    "    \"13\": {\n",
    "        \"label\": \"Serotonin Transporter Gene and Antidepressant Response\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"14\": { \"label\": \"Fluvoxamine for Depression\", \"evidencetype\": [2] },\n",
    "    \"15\": { \"label\": \"SSRIs for PTSD\", \"evidencetype\": [2] },\n",
    "    \"16\": { \"label\": \"Sexual Dysfunction\", \"evidencetype\": [1] },\n",
    "    \"17\": { \"label\": \"Sequenced Depression Treatment\", \"evidencetype\": [1] },\n",
    "    \"18\": { \"label\": \"Serotonin Syndrome\", \"evidencetype\": [1] },\n",
    "    \"19\": { \"label\": \"Serotonin and Inflammation\", \"evidencetype\": [3] },\n",
    "    \"20\": { \"label\": \"Post-Stroke SSRI Use\", \"evidencetype\": [1] },\n",
    "    \"21\": {\n",
    "        \"label\": \"Depression and Cardiovascular Pathology\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"22\": { \"label\": \"SSRIs for Pain\", \"evidencetype\": [1] },\n",
    "    \"23\": { \"label\": \"SSRIs for Bipolar Depression\", \"evidencetype\": [1] },\n",
    "    \"24\": { \"label\": \"SSRI Utilization Patterns\", \"evidencetype\": [1] },\n",
    "    \"25\": { \"label\": \"Escitalopram for Depression\", \"evidencetype\": [1] },\n",
    "    \"26\": { \"label\": \"SSRIs in Dementias\", \"evidencetype\": [1] },\n",
    "    \"27\": { \"label\": \"Bleeding Risk\", \"evidencetype\": [1] },\n",
    "    \"28\": { \"label\": \"Serotonin Receptor Studies\", \"evidencetype\": [2] },\n",
    "    \"29\": { \"label\": \"SSRIs for Weight Management\", \"evidencetype\": [1] },\n",
    "    \"30\": { \"label\": \"Suicide Risk\", \"evidencetype\": [1] },\n",
    "    \"31\": { \"label\": \"Cost-Effectiveness\", \"evidencetype\": [0] },\n",
    "    \"32\": { \"label\": \"Conditioned Fear\", \"evidencetype\": [2] },\n",
    "    \"33\": { \"label\": \"Paroxetine\", \"evidencetype\": [4, 5] },\n",
    "    \"34\": { \"label\": \"SSRIs for Panic Disorder\", \"evidencetype\": [1] },\n",
    "    \"35\": {\n",
    "        \"label\": \"Herbal and Natural Compounds for Depression\",\n",
    "        \"evidencetype\": [2]\n",
    "    },\n",
    "    \"36\": { \"label\": \"Fluvoxamine for Covid 19\", \"evidencetype\": [1] },\n",
    "    \"37\": {\n",
    "        \"label\": \"SSRIs for Generalized Anxiety Disorder (GAD)\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"38\": { \"label\": \"Fracture Risk\", \"evidencetype\": [1] },\n",
    "    \"39\": { \"label\": \"Fluoxetine\", \"evidencetype\": [4, 5] },\n",
    "    \"40\": { \"label\": \"Extrapyramidal Reactions Risk\", \"evidencetype\": [1] },\n",
    "    \"41\": {\n",
    "        \"label\": \"SSRIs Effect on Sleep in Depressed Patients\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"42\": { \"label\": \"Hot Flushes (Menopause)\", \"evidencetype\": [1] },\n",
    "    \"43\": { \"label\": \"SSRIs for Dermatological Diseases\", \"evidencetype\": [1] },\n",
    "    \"44\": {\n",
    "        \"label\": \"Oncopreventive and Oncolytic Properties of SSRIs\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"45\": { \"label\": \"Premature Ejaculation\", \"evidencetype\": [1] },\n",
    "    \"46\": { \"label\": \"QTC Prolongation\", \"evidencetype\": [1] },\n",
    "    \"47\": {\n",
    "        \"label\": \"SSRIs for Premenstrual Dysphoric Disorder (PMDD)\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"48\": { \"label\": \"Depression in Diabetes\", \"evidencetype\": [1] },\n",
    "    \"49\": {\n",
    "        \"label\": \"SSRIs for Depression with Cognitive Impairment\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"50\": { \"label\": \"SSRIs for Eating Disorders\", \"evidencetype\": [1] },\n",
    "    \"51\": { \"label\": \"SSRIs for Alcohol Dependence\", \"evidencetype\": [1] },\n",
    "    \"52\": { \"label\": \"SSRIs for Irritable Bowel Disease\", \"evidencetype\": [1] },\n",
    "    \"53\": {\n",
    "        \"label\": \"Personality Disorder; Learning; Behavioral Effects; Introception\",\n",
    "        \"evidencetype\": [4]\n",
    "    },\n",
    "    \"54\": { \"label\": \"Depression Treatment Review\", \"evidencetype\": [1, 4] },\n",
    "    \"55\": { \"label\": \"Depression in Epileptic Patients\", \"evidencetype\": [1] },\n",
    "    \"56\": { \"label\": \"SSRIs for Autism Spectrum Disorders\", \"evidencetype\": [1] },\n",
    "    \"57\": { \"label\": \"(Sertraline) Drug Delivery\", \"evidencetype\": [2] },\n",
    "    \"58\": { \"label\": \"Depression in Parkinson's Patients\", \"evidencetype\": [] },\n",
    "    \"59\": { \"label\": \"Hepatotoxic Risk\", \"evidencetype\": [2] },\n",
    "    \"60\": { \"label\": \"SSRI Synthesis\", \"evidencetype\": [2] },\n",
    "    \"61\": {\n",
    "        \"label\": \"SSRIs (Fluvoxamine) for Schizophrenia\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"62\": { \"label\": \"SSRIs for Substance Abuse (Cocaine)\", \"evidencetype\": [2] },\n",
    "    \"63\": {\n",
    "        \"label\": \"SSRIs for Social Anxiety Disorder\",\n",
    "        \"evidencetype\": [1, 4]\n",
    "    },\n",
    "    \"64\": { \"label\": \"Sertraline for Depression\", \"evidencetype\": [1] },\n",
    "    \"65\": { \"label\": \"Drug-Drug Interactions\", \"evidencetype\": [1] },\n",
    "    \"66\": { \"label\": \"Ion Channels\", \"evidencetype\": [2] },\n",
    "    \"67\": {\n",
    "        \"label\": \"Methylenedioxymethamphetamine (MDMA) Effects on Serotonin\",\n",
    "        \"evidencetype\": [2]\n",
    "    },\n",
    "    \"68\": { \"label\": \"Genotype Mediated Response to SSRIs\", \"evidencetype\": [2] },\n",
    "    \"69\": { \"label\": \"Hyponatremia Risk\", \"evidencetype\": [1] },\n",
    "    \"70\": {\n",
    "        \"label\": \"Neuroendocrine Effects of Citalopram\",\n",
    "        \"evidencetype\": [3]\n",
    "    },\n",
    "    \"71\": {\n",
    "        \"label\": \"SSRIs for Body Dysmorphic Disorder (BDD)\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"72\": { \"label\": \"Pharmacological Reviews\", \"evidencetype\": [2, 4] },\n",
    "    \"73\": { \"label\": \"Forensic Drug Concentration\", \"evidencetype\": [1] },\n",
    "    \"74\": { \"label\": \"Citalopram for Depression\", \"evidencetype\": [1, 4] },\n",
    "    \"75\": { \"label\": \"SSRIs for Pediatric Anxiety\", \"evidencetype\": [] },\n",
    "    \"76\": { \"label\": \"SSRI Safety Reviews\", \"evidencetype\": [1, 4] },\n",
    "    \"77\": { \"label\": \"Pulmonary Hypertension\", \"evidencetype\": [2] },\n",
    "    \"78\": { \"label\": \"SSRIs as Antifungal Agents\", \"evidencetype\": [2] },\n",
    "    \"79\": { \"label\": \"Geriatric Depression\", \"evidencetype\": [1, 4] },\n",
    "    \"80\": { \"label\": \"Withdrawal Symptoms\", \"evidencetype\": [1] },\n",
    "    \"81\": { \"label\": \"Agomelatine for Depression\", \"evidencetype\": [4] },\n",
    "    \"82\": { \"label\": \"SSRI Efficacy in Depression\", \"evidencetype\": [1, 4] },\n",
    "    \"83\": { \"label\": \"Wastewater Management\", \"evidencetype\": [0] },\n",
    "    \"84\": { \"label\": \"Astrocyte Receptors\", \"evidencetype\": [1] },\n",
    "    \"85\": { \"label\": \"Sertraline\", \"evidencetype\": [5] },\n",
    "    \"86\": { \"label\": \"Vilazodone for Depression\", \"evidencetype\": [1] },\n",
    "    \"87\": { \"label\": \"Depression in Hepatitis Patients\", \"evidencetype\": [1] },\n",
    "    \"88\": {\n",
    "        \"label\": \"SSRIs for Depression after Traumatic Brain Injury\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"89\": { \"label\": \"SSRIs Effects on Dopamine Receptors\", \"evidencetype\": [2] },\n",
    "    \"90\": { \"label\": \"Hyperprolactinemia-related Symptoms\", \"evidencetype\": [2] }, \n",
    "    \"91\": { \"label\": \"SSRIs for Fibromyalgia\", \"evidencetype\": [2] },\n",
    "    \"92\": { \"label\": \"SSRI Use\", \"evidencetype\": [5, 1] },\n",
    "    \"93\": { \"label\": \"SSRIs for Depression in Cancer\", \"evidencetype\": [1] },\n",
    "    \"94\": { \"label\": \"Canine Behavioral Disorders\", \"evidencetype\": [0] }, \n",
    "    \"95\": {\n",
    "        \"label\": \"Transcranial Direct Current Stimulation (tDCS) for Depression\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"96\": { \"label\": \"Gatways to Clinical Trials\", \"evidencetype\": [5] },\n",
    "    \"97\": { \"label\": \"SRRIs Ocular Safety Risk\", \"evidencetype\": [1] },\n",
    "    \"98\": { \"label\": \"Folate for Depression\", \"evidencetype\": [1] },\n",
    "  \n",
    "    \"99\": { \"label\": \"Orofacial Pain Disorders\", \"evidencetype\": [3] },\n",
    "    \"100\": {\n",
    "        \"label\": \"SSRIs for Depression in Kidney Disease Patients\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"101\": { \"label\": \"SSRIs for Enuresis\", \"evidencetype\": [1] },\n",
    "    \"102\": { \"label\": \"St. John's Wort for Depression\", \"evidencetype\": [1] },\n",
    "    \"103\": { \"label\": \"SSRIs for Migraine\", \"evidencetype\": [1] },\n",
    "    \"104\": { \"label\": \"SSRIs for Postpartum Depression\", \"evidencetype\": [1] },\n",
    "    \"105\": { \"label\": \"Behavioral Addictions\", \"evidencetype\": [1] },\n",
    "    \"106\": { \"label\": \"Generic SSRIs\", \"evidencetype\": [1] }, \n",
    "    \"107\": {\n",
    "        \"label\": \"SSRIs in Model Organisms ( C. Elegans and Drosophilia)\",\n",
    "        \"evidencetype\": [2]\n",
    "    },\n",
    "    \"108\": {\n",
    "        \"label\": \"Differential Reinforcement of Low Rate (DRL) Operant Schedule\",\n",
    "        \"evidencetype\": [2]\n",
    "    },\n",
    "    \"109\": { \"label\": \"SSRIs for Dysthymia\", \"evidencetype\": [1] },\n",
    "    \"110\": { \"label\": \"SSRIs for Trichotillomania\", \"evidencetype\": [1] },\n",
    "    \"111\": {\n",
    "        \"label\": \"Selective Serotonin Reuptake Inhibitors\",\n",
    "        \"evidencetype\": [5, 0]\n",
    "    },\n",
    "    \"112\": {\n",
    "        \"label\": \"Modulation of Serotonin Release by Autoreceptors and Heteroreceptors\",\n",
    "        \"evidencetype\": [2]\n",
    "    },\n",
    "    \"113\": { \"label\": \"SSRIs and Galanin in Depression\", \"evidencetype\": [2] },\n",
    "    \"114\": { \"label\": \"SSRIs for Huntington Disease\", \"evidencetype\": [1] },\n",
    "    \"115\": {\n",
    "        \"label\": \"SSRIs for Depression in and Treatment of Multiple Sclerosis\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"116\": {\n",
    "        \"label\": \"SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"117\": {\n",
    "        \"label\": \"Quantification of Dopamine and Serotonin Release and Uptake\",\n",
    "        \"evidencetype\": [2]\n",
    "    },\n",
    "    \"118\": {\n",
    "        \"label\": \"Novel Compounds Synthesis and Antidepressant Potential\",\n",
    "        \"evidencetype\": [2]\n",
    "    },\n",
    "    \"119\": { \"label\": \"Thyroid Hormone for Depression\", \"evidencetype\": [1] },\n",
    "    \"120\": {\n",
    "        \"label\": \"Olfactory Bbulbectomized (OB) Rat Model for Depression\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"121\": {\n",
    "        \"label\": \"SSRIs for Depression in HIV-positive Patients\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"122\": {\n",
    "        \"label\": \"SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients\",\n",
    "        \"evidencetype\": [1]\n",
    "    }, \n",
    "    \"123\": {\n",
    "        \"label\": \"Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor\",\n",
    "        \"evidencetype\": [3]\n",
    "    },\n",
    "    \"124\": { \"label\": \"SSRIs for Smoking Cessation\", \"evidencetype\": [1] },\n",
    "    \"125\": {\n",
    "        \"label\": \"Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression\",\n",
    "        \"evidencetype\": [2]\n",
    "    },\n",
    "    \"126\": { \"label\": \"SSRIs for Syncope\", \"evidencetype\": [1] },\n",
    "    \"127\": { \"label\": \"SSRIs for Tinnitus\", \"evidencetype\": [1] },\n",
    "    \"128\": { \"label\": \"Exercise for Depression\", \"evidencetype\": [1] },\n",
    "    \"129\": { \"label\": \"SSRIs for Narcolepsy\", \"evidencetype\": [1] },\n",
    "    \"130\": { \"label\": \"Risk of Hallucinations\", \"evidencetype\": [1] },\n",
    "    \"131\": {\n",
    "        \"label\": \"SSRIs for Congenital Myasthenic Syndrome (SCCMS)\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"132\": { \"label\": \"Tryptophan Depletion in Depression\", \"evidencetype\": [1] },\n",
    "    \"133\": { \"label\": \"SSRIs for Tourette's Syndrome\", \"evidencetype\": [1] },\n",
    "    \"134\": {\n",
    "        \"label\": \"Adulterants in Weight Loss Supplements\",\n",
    "        \"evidencetype\": [0]\n",
    "    }, \n",
    "    \"135\": { \"label\": \"Risk of Microscopic Colitis\", \"evidencetype\": [1] },\n",
    "    \"136\": { \"label\": \"Critical Psychiatry\", \"evidencetype\": [0] },\n",
    "    \"137\": {\n",
    "        \"label\": \"Animal Models of Obsessive-compulsive Disorder (OCD)\",\n",
    "        \"evidencetype\": [2]\n",
    "    },\n",
    "    \"138\": {\n",
    "        \"label\": \"Psychotic Depression (STOP-PD Study)\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"139\": { \"label\": \"SSRIs for Pediatric OCD\", \"evidencetype\": [1] },\n",
    "    \"140\": {\n",
    "        \"label\": \"Treatment of Paroxetine Induced Sexual Dysfunction\",\n",
    "        \"evidencetype\": [2]\n",
    "    },\n",
    "    \"141\": { \"label\": \"SSRIs and Bariatric Surgery\", \"evidencetype\": [1] },\n",
    "    \"142\": {\n",
    "        \"label\": \"Methylphenidate augmentation in late-life depression\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"143\": { \"label\": \"Psilocybin for Depression\", \"evidencetype\": [1] },\n",
    "    \"144\": { \"label\": \"Risk of Priapism\", \"evidencetype\": [1] }, \n",
    "    \"145\": {\n",
    "        \"label\": \"SSRIs for Depersonalization Disorder\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"146\": {    \n",
    "        \"label\": \"Serotonin Modulation Effects on Primates and Rodents\",\n",
    "        \"evidencetype\":[2, 5]\n",
    "    },\n",
    "    \"147\": {\n",
    "        \"label\": \"Risk of Reversible Rerebral Vasoconstriction Syndrome (RCVS)\",\n",
    "        \"evidencetype\": [1]\n",
    "    },\n",
    "    \"148\": { \"label\": \"Gateways to Clinical Trials\", \"evidencetype\": [5] },\n",
    "    \"149\": {\n",
    "        \"label\": \"Citalopram Effect on Indoleamine Metabolism in Maturing Mouse Brains\",\n",
    "        \"evidencetype\": [2, 5]\n",
    "    },\n",
    "    \"150\": { \"label\": \"Depressed Infertile Women\", \"evidencetype\": [5] },\n",
    "    \"151\": {\n",
    "        \"label\": \"SSRIs for Olfactory reference syndrome (ORS)\",\n",
    "        \"evidencetype\": [5]\n",
    "    }\n",
    "}\n",
    "\"\"\"\n",
    "\n",
    "cluster_labels = json.loads(json_string)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Add info and turn into excel sheet\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Cluster</th>\n",
       "      <th>Nr of Pubs</th>\n",
       "      <th>25th Percentile Year</th>\n",
       "      <th>Median Year</th>\n",
       "      <th>75th Percentile Year</th>\n",
       "      <th>label</th>\n",
       "      <th>Word_0</th>\n",
       "      <th>Word_1</th>\n",
       "      <th>Word_2</th>\n",
       "      <th>Word_3</th>\n",
       "      <th>...</th>\n",
       "      <th>Word_10</th>\n",
       "      <th>Word_11</th>\n",
       "      <th>Word_12</th>\n",
       "      <th>Word_13</th>\n",
       "      <th>Word_14</th>\n",
       "      <th>Word_15</th>\n",
       "      <th>Word_16</th>\n",
       "      <th>Word_17</th>\n",
       "      <th>Word_18</th>\n",
       "      <th>Word_19</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>1198</td>\n",
       "      <td>1996.0</td>\n",
       "      <td>2001.0</td>\n",
       "      <td>2008.0</td>\n",
       "      <td>Serotonin Receptor Studies</td>\n",
       "      <td>ht</td>\n",
       "      <td>fluoxetine</td>\n",
       "      <td>receptor</td>\n",
       "      <td>serotonin</td>\n",
       "      <td>...</td>\n",
       "      <td>citalopram</td>\n",
       "      <td>levels</td>\n",
       "      <td>effect</td>\n",
       "      <td>effects</td>\n",
       "      <td>rats</td>\n",
       "      <td>antidepressant</td>\n",
       "      <td>extracellular</td>\n",
       "      <td>binding</td>\n",
       "      <td>inf</td>\n",
       "      <td>1a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>1092</td>\n",
       "      <td>2014.0</td>\n",
       "      <td>2018.0</td>\n",
       "      <td>2021.0</td>\n",
       "      <td>Aquatic Ecotoxicology</td>\n",
       "      <td>fluoxetine</td>\n",
       "      <td>pharmaceuticals</td>\n",
       "      <td>fish</td>\n",
       "      <td>effects</td>\n",
       "      <td>...</td>\n",
       "      <td>water</td>\n",
       "      <td>zebrafish</td>\n",
       "      <td>treatment</td>\n",
       "      <td>serotonin</td>\n",
       "      <td>aquatic</td>\n",
       "      <td>μg</td>\n",
       "      <td>sertraline</td>\n",
       "      <td>study</td>\n",
       "      <td>exposed</td>\n",
       "      <td>removal</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2 rows × 26 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   Cluster  Nr of Pubs  25th Percentile Year  Median Year  \\\n",
       "0        0        1198                1996.0       2001.0   \n",
       "1        1        1092                2014.0       2018.0   \n",
       "\n",
       "   75th Percentile Year                       label      Word_0  \\\n",
       "0                2008.0  Serotonin Receptor Studies          ht   \n",
       "1                2021.0       Aquatic Ecotoxicology  fluoxetine   \n",
       "\n",
       "            Word_1    Word_2     Word_3  ...     Word_10    Word_11  \\\n",
       "0       fluoxetine  receptor  serotonin  ...  citalopram     levels   \n",
       "1  pharmaceuticals      fish    effects  ...       water  zebrafish   \n",
       "\n",
       "     Word_12    Word_13  Word_14         Word_15        Word_16  Word_17  \\\n",
       "0     effect    effects     rats  antidepressant  extracellular  binding   \n",
       "1  treatment  serotonin  aquatic              μg     sertraline    study   \n",
       "\n",
       "   Word_18  Word_19  \n",
       "0      inf       1a  \n",
       "1  exposed  removal  \n",
       "\n",
       "[2 rows x 26 columns]"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# read summary sheet from output/tables/cluster-explorer/FinalSelect/SingleSolExplorer_alpha0.3_k10_res0.002.xlsx\n",
    "\n",
    "df_summary = pd.read_excel(\"../output/tables/cluster-explorer/FinalSelect/SingleSolExplorer_alpha0.3_k10_res0.002.xlsx\", sheet_name=\"summary\")\n",
    "df_summary['Cluster'] = df_summary['Cluster'].astype(int)\n",
    "df_summary.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>label</th>\n",
       "      <th>cluster</th>\n",
       "      <th>clinical</th>\n",
       "      <th>in_vivo_in_vitro</th>\n",
       "      <th>mixed</th>\n",
       "      <th>review</th>\n",
       "      <th>garbage</th>\n",
       "      <th>nr_of_pubs</th>\n",
       "      <th>25th_percentile_year</th>\n",
       "      <th>median_year</th>\n",
       "      <th>75th_percentile_year</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serotonin Receptor Studies</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1198</td>\n",
       "      <td>1996.0</td>\n",
       "      <td>2001.0</td>\n",
       "      <td>2008.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Aquatic Ecotoxicology</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1092</td>\n",
       "      <td>2014.0</td>\n",
       "      <td>2018.0</td>\n",
       "      <td>2021.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        label  cluster  clinical  in_vivo_in_vitro  mixed  \\\n",
       "0  Serotonin Receptor Studies        0         0                 1      0   \n",
       "1       Aquatic Ecotoxicology        1         0                 0      0   \n",
       "\n",
       "   review  garbage  nr_of_pubs  25th_percentile_year  median_year  \\\n",
       "0       0        0        1198                1996.0       2001.0   \n",
       "1       0        0        1092                2014.0       2018.0   \n",
       "\n",
       "   75th_percentile_year  \n",
       "0                2008.0  \n",
       "1                2021.0  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def process_cluster_data(cluster_labels, df_summary):\n",
    "    # Create DataFrame from cluster_labels dictionary\n",
    "    df_clusters = pd.DataFrame(cluster_labels).T\n",
    "    df_clusters['cluster'] = df_clusters.index.astype(int)\n",
    "\n",
    "    # Add columns for each evidence type\n",
    "    evidence_types = {\n",
    "        \"clinical\": 1,\n",
    "        \"in_vivo_in_vitro\": 2,\n",
    "        \"mixed\": 3,\n",
    "        \"review\": 4,\n",
    "        \"garbage\": 5\n",
    "    }\n",
    "    for col_name, evid_type in evidence_types.items():\n",
    "        df_clusters[col_name] = df_clusters[\"evidencetype\"].apply(lambda x: 1 if evid_type in x else 0)\n",
    "\n",
    "    # Remove the evidencetype column\n",
    "    df_clusters.drop(columns=\"evidencetype\", inplace=True)\n",
    "\n",
    "    # Merge with df_summary on cluster and Cluster columns\n",
    "    df_clusters = df_clusters.merge(\n",
    "        df_summary[['Cluster', 'Nr of Pubs', '25th Percentile Year', 'Median Year', '75th Percentile Year']],\n",
    "        left_on=\"cluster\",\n",
    "        right_on=\"Cluster\",\n",
    "        how=\"left\"\n",
    "    )\n",
    "\n",
    "    # Drop the Cluster column\n",
    "    df_clusters.drop(columns=\"Cluster\", inplace=True)\n",
    "\n",
    "    # Make all column names lowercase and replace spaces with underscores\n",
    "    df_clusters.columns = [col.lower().replace(' ', '_') for col in df_clusters.columns]\n",
    "\n",
    "    return df_clusters\n",
    "\n",
    "# Use the function\n",
    "df_cluster_info = process_cluster_data(cluster_labels, df_summary)\n",
    "df_cluster_info.head(2)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# add categories to it\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "json_string = \"\"\"\n",
    "{\n",
    "  \"Pharmacology\": {\n",
    "    \"Pharmacodynamics\": {\n",
    "      \"Mechanism of action\": [0, 2, 28,84, 89, 112], \n",
    "      \"Animal Models of Disorders\": [12, 32, 108, 120, 137],\n",
    "      \"OtherPharmacodynamics\": [6, 11, 66, 67, 78, 107, 123, 125, 140]\n",
    "    },\n",
    "    \"Pharmacokinetics\": [5, 57],\n",
    "    \"Pharmacogenetics\": [13, 68],\n",
    "    \"Analytical Methods\": [3, 117],\n",
    "    \"Biomarker Search\": [10, 122],\n",
    "    \"OtherPharmacology\": [2, 10, 60,70, 72, 118]\n",
    "  },\n",
    "  \"Indications\": {\n",
    "    \"Disorders\": {\n",
    "      \"Depression\": [\n",
    "        7, 8, 12, 13, 14, 17, 21, 25, 41, 48, 54, 55, 58, 64, 74, 79, 81, 82,\n",
    "        86, 87, 88, 93, 95, 98, 100, 102, 113, 115, 116, 119, 120, 121, 122,\n",
    "        125, 128, 132, 138, 141, 142, 23, 47, 19, 41\n",
    "      ],\n",
    "      \"Anxiety\": [32, 37, 63, 75],\n",
    "      \"OCD\": [4, 137, 139],\n",
    "      \"Weight and Eating Disorders\": [29, 50],\n",
    "      \"Substance Abuse\": [51, 124], \n",
    "      \"OtherDisorders\": [\n",
    "        15, 22, 34, 36, 42, 43, 45, 52, 56, 61, 62, 71, 77,78, 91, 99, 101, 103,\n",
    "        104, 105, 109, 110, 114, 115, 123, 126, 127, 129, 133, 144\n",
    "      ]\n",
    "    },\n",
    "    \"Special Populations\": {\n",
    "      \"Pediatrics\": [7, 56, 75, 139],\n",
    "      \"Geriatrics\": [26, 38, 49, 58, 65, 69, 79, 115, 141],\n",
    "      \"OtherSpecialPop\": [20, 21, 48, 55, 87, 88, 93, 100, 116, 121, 131]\n",
    "    },\n",
    "    \"OtherIndications\": []\n",
    "  },\n",
    "  \"Safety\": {\n",
    "    \"Prenatal Exposure\": [2, 11],\n",
    "    \"Pregnancy\": [2],\n",
    "    \"Suicide\": [7, 30],\n",
    "    \"Sexual Dysfunction\": [16, 140, 143],\n",
    "    \"Toxicity\": [18, 59],\n",
    "    \"Bleeding Risk\": [27],\n",
    "    \"Cardiovascular\": [46],\n",
    "    \"OtherSafety\": [38, 40, 44, 65, 69, 73, 76, 80, 90, 97, 99,106, 130, 135, 147]\n",
    "  },\n",
    "  \"OtherRoot\": {\n",
    "    \"Drugs\": {\n",
    "      \"Paroxetine\": [9, 33, 140],\n",
    "      \"Fluoxetine\": [39, 134],\n",
    "      \"Fluoxamine\": [14],\n",
    "      \"Escitalopram\": [25],\n",
    "      \"Sertraline\": [64, 85],\n",
    "      \"Agomelatine\": [81],\n",
    "      \"Vilazodone\": [86],\n",
    "      \"Psilocybin\": [142]\n",
    "    },\n",
    "    \"Ecotoxicology\": [1, 83],\n",
    "    \"Alternative Treatments\": [8, 35],\n",
    "    \"Drug Utilization Patterns\": [24,106],\n",
    "    \"Cost-Effectineness\": [31],\n",
    "    \"Other\": [53,92, 94, 96, 105, 111, 134, 136, 145, 146, 147, 148,149,150,151]\n",
    "  }\n",
    "}\n",
    "\"\"\"\n",
    "\n",
    "tree_hierachy = json.loads(json_string)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "nr unique clusters:  152\n",
      "Entries:  203\n",
      "Entries after grouping:  152\n",
      "Total Number of branches:  46\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cluster</th>\n",
       "      <th>Pharmacology</th>\n",
       "      <th>Pharmacodynamics</th>\n",
       "      <th>Mechanism of action</th>\n",
       "      <th>Animal Models of Disorders</th>\n",
       "      <th>OtherPharmacodynamics</th>\n",
       "      <th>Pharmacokinetics</th>\n",
       "      <th>Pharmacogenetics</th>\n",
       "      <th>Analytical Methods</th>\n",
       "      <th>Biomarker Search</th>\n",
       "      <th>...</th>\n",
       "      <th>Escitalopram</th>\n",
       "      <th>Sertraline</th>\n",
       "      <th>Agomelatine</th>\n",
       "      <th>Vilazodone</th>\n",
       "      <th>Psilocybin</th>\n",
       "      <th>Ecotoxicology</th>\n",
       "      <th>Alternative Treatments</th>\n",
       "      <th>Drug Utilization Patterns</th>\n",
       "      <th>Cost-Effectineness</th>\n",
       "      <th>Other</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2 rows × 47 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   cluster  Pharmacology  Pharmacodynamics  Mechanism of action  \\\n",
       "0        0           1.0               1.0                  1.0   \n",
       "1        1           0.0               0.0                  0.0   \n",
       "\n",
       "   Animal Models of Disorders  OtherPharmacodynamics  Pharmacokinetics  \\\n",
       "0                         0.0                    0.0               0.0   \n",
       "1                         0.0                    0.0               0.0   \n",
       "\n",
       "   Pharmacogenetics  Analytical Methods  Biomarker Search  ...  Escitalopram  \\\n",
       "0               0.0                 0.0               0.0  ...           0.0   \n",
       "1               0.0                 0.0               0.0  ...           0.0   \n",
       "\n",
       "   Sertraline  Agomelatine  Vilazodone  Psilocybin  Ecotoxicology  \\\n",
       "0         0.0          0.0         0.0         0.0            0.0   \n",
       "1         0.0          0.0         0.0         0.0            1.0   \n",
       "\n",
       "   Alternative Treatments  Drug Utilization Patterns  Cost-Effectineness  \\\n",
       "0                     0.0                        0.0                 0.0   \n",
       "1                     0.0                        0.0                 0.0   \n",
       "\n",
       "   Other  \n",
       "0    0.0  \n",
       "1    0.0  \n",
       "\n",
       "[2 rows x 47 columns]"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load the JSON string\n",
    "tree_hierarchy = json.loads(json_string)\n",
    "\n",
    "# Function to convert the hierarchy into a list of dictionaries\n",
    "def flatten_hierarchy(hierarchy, path=None):\n",
    "    if path is None:\n",
    "        path = []\n",
    "    if isinstance(hierarchy, dict):\n",
    "        result = []\n",
    "        for key, value in hierarchy.items():\n",
    "            result.extend(flatten_hierarchy(value, path + [key]))\n",
    "        return result\n",
    "    else:\n",
    "        return [{**{level: 1 for level in path}, 'cluster': cluster} for cluster in hierarchy]\n",
    "\n",
    "# Flatten the hierarchy\n",
    "flattened_data = flatten_hierarchy(tree_hierarchy)\n",
    "\n",
    "# Convert to DataFrame\n",
    "df_hierarchy = pd.DataFrame(flattened_data).explode('cluster').reset_index(drop=True)\n",
    "\n",
    "# Replace NaN with 0 for missing hierarchy levels\n",
    "df_hierarchy = df_hierarchy.fillna(0)\n",
    "\n",
    "# Convert the 'cluster' column to int for merging\n",
    "df_hierarchy['cluster'] = df_hierarchy['cluster'].astype(int)\n",
    "\n",
    "print('nr unique clusters: ', df_hierarchy['cluster'].nunique())\n",
    "print('Entries: ', df_hierarchy.shape[0])\n",
    "\n",
    "df_hierarchy = df_hierarchy.groupby('cluster').max().reset_index()\n",
    "print('Entries after grouping: ', df_hierarchy.shape[0])\n",
    "\n",
    "print('Total Number of branches: ', df_hierarchy.shape[1] - 1) \n",
    "\n",
    "df_hierarchy.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(152, 57)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>label</th>\n",
       "      <th>cluster</th>\n",
       "      <th>clinical</th>\n",
       "      <th>in_vivo_in_vitro</th>\n",
       "      <th>mixed</th>\n",
       "      <th>review</th>\n",
       "      <th>garbage</th>\n",
       "      <th>nr_of_pubs</th>\n",
       "      <th>25th_percentile_year</th>\n",
       "      <th>median_year</th>\n",
       "      <th>...</th>\n",
       "      <th>Escitalopram</th>\n",
       "      <th>Sertraline</th>\n",
       "      <th>Agomelatine</th>\n",
       "      <th>Vilazodone</th>\n",
       "      <th>Psilocybin</th>\n",
       "      <th>Ecotoxicology</th>\n",
       "      <th>Alternative Treatments</th>\n",
       "      <th>Drug Utilization Patterns</th>\n",
       "      <th>Cost-Effectineness</th>\n",
       "      <th>Other</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>Risk of Reversible Rerebral Vasoconstriction S...</td>\n",
       "      <td>147</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>15</td>\n",
       "      <td>1996.50</td>\n",
       "      <td>2000.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>Gateways to Clinical Trials</td>\n",
       "      <td>148</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>15</td>\n",
       "      <td>2010.00</td>\n",
       "      <td>2015.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>149</th>\n",
       "      <td>Citalopram Effect on Indoleamine Metabolism in...</td>\n",
       "      <td>149</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>11</td>\n",
       "      <td>2004.00</td>\n",
       "      <td>2005.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>Depressed Infertile Women</td>\n",
       "      <td>150</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>8</td>\n",
       "      <td>1986.00</td>\n",
       "      <td>1987.5</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td>SSRIs for Olfactory reference syndrome (ORS)</td>\n",
       "      <td>151</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>8</td>\n",
       "      <td>2010.25</td>\n",
       "      <td>2013.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 57 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                 label  cluster  clinical  \\\n",
       "147  Risk of Reversible Rerebral Vasoconstriction S...      147         1   \n",
       "148                        Gateways to Clinical Trials      148         0   \n",
       "149  Citalopram Effect on Indoleamine Metabolism in...      149         0   \n",
       "150                          Depressed Infertile Women      150         0   \n",
       "151       SSRIs for Olfactory reference syndrome (ORS)      151         0   \n",
       "\n",
       "     in_vivo_in_vitro  mixed  review  garbage  nr_of_pubs  \\\n",
       "147                 0      0       0        0          15   \n",
       "148                 0      0       0        1          15   \n",
       "149                 1      0       0        1          11   \n",
       "150                 0      0       0        1           8   \n",
       "151                 0      0       0        1           8   \n",
       "\n",
       "     25th_percentile_year  median_year  ...  Escitalopram  Sertraline  \\\n",
       "147               1996.50       2000.0  ...           0.0         0.0   \n",
       "148               2010.00       2015.0  ...           0.0         0.0   \n",
       "149               2004.00       2005.0  ...           0.0         0.0   \n",
       "150               1986.00       1987.5  ...           0.0         0.0   \n",
       "151               2010.25       2013.0  ...           0.0         0.0   \n",
       "\n",
       "     Agomelatine  Vilazodone  Psilocybin  Ecotoxicology  \\\n",
       "147          0.0         0.0         0.0            0.0   \n",
       "148          0.0         0.0         0.0            0.0   \n",
       "149          0.0         0.0         0.0            0.0   \n",
       "150          0.0         0.0         0.0            0.0   \n",
       "151          0.0         0.0         0.0            0.0   \n",
       "\n",
       "     Alternative Treatments  Drug Utilization Patterns  Cost-Effectineness  \\\n",
       "147                     0.0                        0.0                 0.0   \n",
       "148                     0.0                        0.0                 0.0   \n",
       "149                     0.0                        0.0                 0.0   \n",
       "150                     0.0                        0.0                 0.0   \n",
       "151                     0.0                        0.0                 0.0   \n",
       "\n",
       "     Other  \n",
       "147    1.0  \n",
       "148    1.0  \n",
       "149    1.0  \n",
       "150    1.0  \n",
       "151    1.0  \n",
       "\n",
       "[5 rows x 57 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# merge on cluster with df_cluster_info\n",
    "df_cluster_info = df_cluster_info.merge(df_hierarchy, on='cluster', how='left')\n",
    "print(df_cluster_info.shape)\n",
    "df_cluster_info.tail()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "p = '/Users/jlq293/Projects/Study-1-Bibliometrics/output/cluster-qualifications/K10/'\n",
    "df_cluster_info.to_excel(p + 'ClusterInfoLabelTree.xlsx', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['label', 'cluster', 'clinical', 'in_vivo_in_vitro', 'mixed', 'review',\n",
       "       'garbage', 'nr_of_pubs', '25th_percentile_year', 'median_year',\n",
       "       '75th_percentile_year', 'Pharmacology', 'Pharmacodynamics',\n",
       "       'Mechanism of action', 'Animal Models of Disorders',\n",
       "       'OtherPharmacodynamics', 'Pharmacokinetics', 'Pharmacogenetics',\n",
       "       'Analytical Methods', 'Biomarker Search', 'OtherPharmacology',\n",
       "       'Indications', 'Disorders', 'Depression', 'Anxiety', 'OCD',\n",
       "       'Weight and Eating Disorders', 'Substance Abuse', 'OtherDisorders',\n",
       "       'Special Populations', 'Pediatrics', 'Geriatrics', 'OtherSpecialPop',\n",
       "       'Safety', 'Prenatal Exposure', 'Pregnancy', 'Suicide',\n",
       "       'Sexual Dysfunction', 'Toxicity', 'Bleeding Risk', 'Cardiovascular',\n",
       "       'OtherSafety', 'OtherRoot', 'Drugs', 'Paroxetine', 'Fluoxetine',\n",
       "       'Fluoxamine', 'Escitalopram', 'Sertraline', 'Agomelatine', 'Vilazodone',\n",
       "       'Psilocybin', 'Ecotoxicology', 'Alternative Treatments',\n",
       "       'Drug Utilization Patterns', 'Cost-Effectineness', 'Other'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cluster_info.columns"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Build Full Tree Incl Labels\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{0: 'Serotonin Receptor Studies',\n",
       " 1: 'Aquatic Ecotoxicology',\n",
       " 2: 'Prenatal Exposure',\n",
       " 3: 'Quantification of SSRIs in Biological Samples',\n",
       " 4: 'Treatment of Obsessive-Compulsive Disorder (OCD)',\n",
       " 5: 'SSRIs and the Cytochrome P450 System',\n",
       " 6: 'Neurogenesis',\n",
       " 7: 'Pediatric Depression',\n",
       " 8: 'Herbal and Natural Compounds for Depression, using Forced Swimming Test',\n",
       " 9: 'Paroxetine Binding',\n",
       " 10: 'Neural Processing of Emotional Cues',\n",
       " 11: 'Prenatal Exposure',\n",
       " 12: 'Forced Swimming Test',\n",
       " 13: 'Serotonin Transporter Gene and Antidepressant Response',\n",
       " 14: 'Fluvoxamine for Depression',\n",
       " 15: 'SSRIs for PTSD',\n",
       " 16: 'Sexual Dysfunction',\n",
       " 17: 'Sequenced Depression Treatment',\n",
       " 18: 'Serotonin Syndrome',\n",
       " 19: 'Serotonin and Inflammation',\n",
       " 20: 'Post-Stroke SSRI Use',\n",
       " 21: 'Depression and Cardiovascular Pathology',\n",
       " 22: 'SSRIs for Pain',\n",
       " 23: 'SSRIs for Bipolar Depression',\n",
       " 24: 'SSRI Utilization Patterns',\n",
       " 25: 'Escitalopram for Depression',\n",
       " 26: 'SSRIs in Dementias',\n",
       " 27: 'Bleeding Risk',\n",
       " 28: 'Serotonin Receptor Studies',\n",
       " 29: 'SSRIs for Weight Management',\n",
       " 30: 'Suicide Risk',\n",
       " 31: 'Cost-Effectiveness',\n",
       " 32: 'Conditioned Fear',\n",
       " 33: 'Paroxetine',\n",
       " 34: 'SSRIs for Panic Disorder',\n",
       " 35: 'Herbal and Natural Compounds for Depression',\n",
       " 36: 'Fluvoxamine for Covid 19',\n",
       " 37: 'SSRIs for Generalized Anxiety Disorder (GAD)',\n",
       " 38: 'Fracture Risk',\n",
       " 39: 'Fluoxetine',\n",
       " 40: 'Extrapyramidal Reactions Risk',\n",
       " 41: 'SSRIs Effect on Sleep in Depressed Patients',\n",
       " 42: 'Hot Flushes (Menopause)',\n",
       " 43: 'SSRIs for Dermatological Diseases',\n",
       " 44: 'Oncopreventive and Oncolytic Properties of SSRIs',\n",
       " 45: 'Premature Ejaculation',\n",
       " 46: 'QTC Prolongation',\n",
       " 47: 'SSRIs for Premenstrual Dysphoric Disorder (PMDD)',\n",
       " 48: 'Depression in Diabetes',\n",
       " 49: 'SSRIs for Depression with Cognitive Impairment',\n",
       " 50: 'SSRIs for Eating Disorders',\n",
       " 51: 'SSRIs for Alcohol Dependence',\n",
       " 52: 'SSRIs for Irritable Bowel Disease',\n",
       " 53: 'Personality Disorder; Learning; Behavioral Effects; Introception',\n",
       " 54: 'Depression Treatment Review',\n",
       " 55: 'Depression in Epileptic Patients',\n",
       " 56: 'SSRIs for Autism Spectrum Disorders',\n",
       " 57: '(Sertraline) Drug Delivery',\n",
       " 58: \"Depression in Parkinson's Patients\",\n",
       " 59: 'Hepatotoxic Risk',\n",
       " 60: 'SSRI Synthesis',\n",
       " 61: 'SSRIs (Fluvoxamine) for Schizophrenia',\n",
       " 62: 'SSRIs for Substance Abuse (Cocaine)',\n",
       " 63: 'SSRIs for Social Anxiety Disorder',\n",
       " 64: 'Sertraline for Depression',\n",
       " 65: 'Drug-Drug Interactions',\n",
       " 66: 'Ion Channels',\n",
       " 67: 'Methylenedioxymethamphetamine (MDMA) Effects on Serotonin',\n",
       " 68: 'Genotype Mediated Response to SSRIs',\n",
       " 69: 'Hyponatremia Risk',\n",
       " 70: 'Neuroendocrine Effects of Citalopram',\n",
       " 71: 'SSRIs for Body Dysmorphic Disorder (BDD)',\n",
       " 72: 'Pharmacological Reviews',\n",
       " 73: 'Forensic Drug Concentration',\n",
       " 74: 'Citalopram for Depression',\n",
       " 75: 'SSRIs for Pediatric Anxiety',\n",
       " 76: 'SSRI Safety Reviews',\n",
       " 77: 'Pulmonary Hypertension',\n",
       " 78: 'SSRIs as Antifungal Agents',\n",
       " 79: 'Geriatric Depression',\n",
       " 80: 'Withdrawal Symptoms',\n",
       " 81: 'Agomelatine for Depression',\n",
       " 82: 'SSRI Efficacy in Depression',\n",
       " 83: 'Wastewater Management',\n",
       " 84: 'Astrocyte Receptors',\n",
       " 85: 'Sertraline',\n",
       " 86: 'Vilazodone for Depression',\n",
       " 87: 'Depression in Hepatitis Patients',\n",
       " 88: 'SSRIs for Depression after Traumatic Brain Injury',\n",
       " 89: 'SSRIs Effects on Dopamine Receptors',\n",
       " 90: 'Hyperprolactinemia-related Symptoms',\n",
       " 91: 'SSRIs for Fibromyalgia',\n",
       " 92: 'SSRI Use',\n",
       " 93: 'SSRIs for Depression in Cancer',\n",
       " 94: 'Canine Behavioral Disorders',\n",
       " 95: 'Transcranial Direct Current Stimulation (tDCS) for Depression',\n",
       " 96: 'Gatways to Clinical Trials',\n",
       " 97: 'SRRIs Ocular Safety Risk',\n",
       " 98: 'Folate for Depression',\n",
       " 99: 'Orofacial Pain Disorders',\n",
       " 100: 'SSRIs for Depression in Kidney Disease Patients',\n",
       " 101: 'SSRIs for Enuresis',\n",
       " 102: \"St. John's Wort for Depression\",\n",
       " 103: 'SSRIs for Migraine',\n",
       " 104: 'SSRIs for Postpartum Depression',\n",
       " 105: 'Behavioral Addictions',\n",
       " 106: 'Generic SSRIs',\n",
       " 107: 'SSRIs in Model Organisms ( C. Elegans and Drosophilia)',\n",
       " 108: 'Differential Reinforcement of Low Rate (DRL) Operant Schedule',\n",
       " 109: 'SSRIs for Dysthymia',\n",
       " 110: 'SSRIs for Trichotillomania',\n",
       " 111: 'Selective Serotonin Reuptake Inhibitors',\n",
       " 112: 'Modulation of Serotonin Release by Autoreceptors and Heteroreceptors',\n",
       " 113: 'SSRIs and Galanin in Depression',\n",
       " 114: 'SSRIs for Huntington Disease',\n",
       " 115: 'SSRIs for Depression in and Treatment of Multiple Sclerosis',\n",
       " 116: 'SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients',\n",
       " 117: 'Quantification of Dopamine and Serotonin Release and Uptake',\n",
       " 118: 'Novel Compounds Synthesis and Antidepressant Potential',\n",
       " 119: 'Thyroid Hormone for Depression',\n",
       " 120: 'Olfactory Bbulbectomized (OB) Rat Model for Depression',\n",
       " 121: 'SSRIs for Depression in HIV-positive Patients',\n",
       " 122: 'SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients',\n",
       " 123: 'Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor',\n",
       " 124: 'SSRIs for Smoking Cessation',\n",
       " 125: 'Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression',\n",
       " 126: 'SSRIs for Syncope',\n",
       " 127: 'SSRIs for Tinnitus',\n",
       " 128: 'Exercise for Depression',\n",
       " 129: 'SSRIs for Narcolepsy',\n",
       " 130: 'Risk of Hallucinations',\n",
       " 131: 'SSRIs for Congenital Myasthenic Syndrome (SCCMS)',\n",
       " 132: 'Tryptophan Depletion in Depression',\n",
       " 133: \"SSRIs for Tourette's Syndrome\",\n",
       " 134: 'Adulterants in Weight Loss Supplements',\n",
       " 135: 'Risk of Microscopic Colitis',\n",
       " 136: 'Critical Psychiatry',\n",
       " 137: 'Animal Models of Obsessive-compulsive Disorder (OCD)',\n",
       " 138: 'Psychotic Depression (STOP-PD Study)',\n",
       " 139: 'SSRIs for Pediatric OCD',\n",
       " 140: 'Treatment of Paroxetine Induced Sexual Dysfunction',\n",
       " 141: 'SSRIs and Bariatric Surgery',\n",
       " 142: 'Methylphenidate augmentation in late-life depression',\n",
       " 143: 'Psilocybin for Depression',\n",
       " 144: 'Risk of Priapism',\n",
       " 145: 'SSRIs for Depersonalization Disorder',\n",
       " 146: 'Serotonin Modulation Effects on Primates and Rodents',\n",
       " 147: 'Risk of Reversible Rerebral Vasoconstriction Syndrome (RCVS)',\n",
       " 148: 'Gateways to Clinical Trials',\n",
       " 149: 'Citalopram Effect on Indoleamine Metabolism in Maturing Mouse Brains',\n",
       " 150: 'Depressed Infertile Women',\n",
       " 151: 'SSRIs for Olfactory reference syndrome (ORS)'}"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cluster_label_dict = dict(zip(df_cluster_info.cluster, df_cluster_info.label))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      "  \"Pharmacology\": {\n",
      "    \"Pharmacodynamics\": {\n",
      "      \"Mechanism of action\": [\n",
      "        \"Serotonin Receptor Studies\",\n",
      "        \"Prenatal Exposure\",\n",
      "        \"Serotonin Receptor Studies\",\n",
      "        \"Astrocyte Receptors\",\n",
      "        \"SSRIs Effects on Dopamine Receptors\",\n",
      "        \"Modulation of Serotonin Release by Autoreceptors and Heteroreceptors\"\n",
      "      ],\n",
      "      \"Animal Models of Disorders\": [\n",
      "        \"Forced Swimming Test\",\n",
      "        \"Conditioned Fear\",\n",
      "        \"Differential Reinforcement of Low Rate (DRL) Operant Schedule\",\n",
      "        \"Olfactory Bbulbectomized (OB) Rat Model for Depression\",\n",
      "        \"Animal Models of Obsessive-compulsive Disorder (OCD)\"\n",
      "      ],\n",
      "      \"OtherPharmacodynamics\": [\n",
      "        \"Neurogenesis\",\n",
      "        \"Prenatal Exposure\",\n",
      "        \"Ion Channels\",\n",
      "        \"Methylenedioxymethamphetamine (MDMA) Effects on Serotonin\",\n",
      "        \"SSRIs as Antifungal Agents\",\n",
      "        \"SSRIs in Model Organisms ( C. Elegans and Drosophilia)\",\n",
      "        \"Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor\",\n",
      "        \"Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression\",\n",
      "        \"Treatment of Paroxetine Induced Sexual Dysfunction\"\n",
      "      ]\n",
      "    },\n",
      "    \"Pharmacokinetics\": [\n",
      "      \"SSRIs and the Cytochrome P450 System\",\n",
      "      \"(Sertraline) Drug Delivery\"\n",
      "    ],\n",
      "    \"Pharmacogenetics\": [\n",
      "      \"Serotonin Transporter Gene and Antidepressant Response\",\n",
      "      \"Genotype Mediated Response to SSRIs\"\n",
      "    ],\n",
      "    \"Analytical Methods\": [\n",
      "      \"Quantification of SSRIs in Biological Samples\",\n",
      "      \"Quantification of Dopamine and Serotonin Release and Uptake\"\n",
      "    ],\n",
      "    \"Biomarker Search\": [\n",
      "      \"Neural Processing of Emotional Cues\",\n",
      "      \"SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients\"\n",
      "    ],\n",
      "    \"OtherPharmacology\": [\n",
      "      \"Prenatal Exposure\",\n",
      "      \"Neural Processing of Emotional Cues\",\n",
      "      \"SSRI Synthesis\",\n",
      "      \"Neuroendocrine Effects of Citalopram\",\n",
      "      \"Pharmacological Reviews\",\n",
      "      \"Novel Compounds Synthesis and Antidepressant Potential\"\n",
      "    ]\n",
      "  },\n",
      "  \"Indications\": {\n",
      "    \"Disorders\": {\n",
      "      \"Depression\": [\n",
      "        \"Pediatric Depression\",\n",
      "        \"Herbal and Natural Compounds for Depression, using Forced Swimming Test\",\n",
      "        \"Forced Swimming Test\",\n",
      "        \"Serotonin Transporter Gene and Antidepressant Response\",\n",
      "        \"Fluvoxamine for Depression\",\n",
      "        \"Sequenced Depression Treatment\",\n",
      "        \"Depression and Cardiovascular Pathology\",\n",
      "        \"Escitalopram for Depression\",\n",
      "        \"SSRIs Effect on Sleep in Depressed Patients\",\n",
      "        \"Depression in Diabetes\",\n",
      "        \"Depression Treatment Review\",\n",
      "        \"Depression in Epileptic Patients\",\n",
      "        \"Depression in Parkinson's Patients\",\n",
      "        \"Sertraline for Depression\",\n",
      "        \"Citalopram for Depression\",\n",
      "        \"Geriatric Depression\",\n",
      "        \"Agomelatine for Depression\",\n",
      "        \"SSRI Efficacy in Depression\",\n",
      "        \"Vilazodone for Depression\",\n",
      "        \"Depression in Hepatitis Patients\",\n",
      "        \"SSRIs for Depression after Traumatic Brain Injury\",\n",
      "        \"SSRIs for Depression in Cancer\",\n",
      "        \"Transcranial Direct Current Stimulation (tDCS) for Depression\",\n",
      "        \"Folate for Depression\",\n",
      "        \"SSRIs for Depression in Kidney Disease Patients\",\n",
      "        \"St. John's Wort for Depression\",\n",
      "        \"SSRIs and Galanin in Depression\",\n",
      "        \"SSRIs for Depression in and Treatment of Multiple Sclerosis\",\n",
      "        \"SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients\",\n",
      "        \"Thyroid Hormone for Depression\",\n",
      "        \"Olfactory Bbulbectomized (OB) Rat Model for Depression\",\n",
      "        \"SSRIs for Depression in HIV-positive Patients\",\n",
      "        \"SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients\",\n",
      "        \"Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression\",\n",
      "        \"Exercise for Depression\",\n",
      "        \"Tryptophan Depletion in Depression\",\n",
      "        \"Psychotic Depression (STOP-PD Study)\",\n",
      "        \"SSRIs and Bariatric Surgery\",\n",
      "        \"Methylphenidate augmentation in late-life depression\",\n",
      "        \"SSRIs for Bipolar Depression\",\n",
      "        \"SSRIs for Premenstrual Dysphoric Disorder (PMDD)\",\n",
      "        \"Serotonin and Inflammation\",\n",
      "        \"SSRIs Effect on Sleep in Depressed Patients\"\n",
      "      ],\n",
      "      \"Anxiety\": [\n",
      "        \"Conditioned Fear\",\n",
      "        \"SSRIs for Generalized Anxiety Disorder (GAD)\",\n",
      "        \"SSRIs for Social Anxiety Disorder\",\n",
      "        \"SSRIs for Pediatric Anxiety\"\n",
      "      ],\n",
      "      \"OCD\": [\n",
      "        \"Treatment of Obsessive-Compulsive Disorder (OCD)\",\n",
      "        \"Animal Models of Obsessive-compulsive Disorder (OCD)\",\n",
      "        \"SSRIs for Pediatric OCD\"\n",
      "      ],\n",
      "      \"Weight and Eating Disorders\": [\n",
      "        \"SSRIs for Weight Management\",\n",
      "        \"SSRIs for Eating Disorders\"\n",
      "      ],\n",
      "      \"Substance Abuse\": [\n",
      "        \"SSRIs for Alcohol Dependence\",\n",
      "        \"SSRIs for Smoking Cessation\"\n",
      "      ],\n",
      "      \"OtherDisorders\": [\n",
      "        \"SSRIs for PTSD\",\n",
      "        \"SSRIs for Pain\",\n",
      "        \"SSRIs for Panic Disorder\",\n",
      "        \"Fluvoxamine for Covid 19\",\n",
      "        \"Hot Flushes (Menopause)\",\n",
      "        \"SSRIs for Dermatological Diseases\",\n",
      "        \"Premature Ejaculation\",\n",
      "        \"SSRIs for Irritable Bowel Disease\",\n",
      "        \"SSRIs for Autism Spectrum Disorders\",\n",
      "        \"SSRIs (Fluvoxamine) for Schizophrenia\",\n",
      "        \"SSRIs for Substance Abuse (Cocaine)\",\n",
      "        \"SSRIs for Body Dysmorphic Disorder (BDD)\",\n",
      "        \"Pulmonary Hypertension\",\n",
      "        \"SSRIs as Antifungal Agents\",\n",
      "        \"SSRIs for Fibromyalgia\",\n",
      "        \"Orofacial Pain Disorders\",\n",
      "        \"SSRIs for Enuresis\",\n",
      "        \"SSRIs for Migraine\",\n",
      "        \"SSRIs for Postpartum Depression\",\n",
      "        \"Behavioral Addictions\",\n",
      "        \"SSRIs for Dysthymia\",\n",
      "        \"SSRIs for Trichotillomania\",\n",
      "        \"SSRIs for Huntington Disease\",\n",
      "        \"SSRIs for Depression in and Treatment of Multiple Sclerosis\",\n",
      "        \"Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor\",\n",
      "        \"SSRIs for Syncope\",\n",
      "        \"SSRIs for Tinnitus\",\n",
      "        \"SSRIs for Narcolepsy\",\n",
      "        \"SSRIs for Tourette's Syndrome\",\n",
      "        \"Risk of Priapism\"\n",
      "      ]\n",
      "    },\n",
      "    \"Special Populations\": {\n",
      "      \"Pediatrics\": [\n",
      "        \"Pediatric Depression\",\n",
      "        \"SSRIs for Autism Spectrum Disorders\",\n",
      "        \"SSRIs for Pediatric Anxiety\",\n",
      "        \"SSRIs for Pediatric OCD\"\n",
      "      ],\n",
      "      \"Geriatrics\": [\n",
      "        \"SSRIs in Dementias\",\n",
      "        \"Fracture Risk\",\n",
      "        \"SSRIs for Depression with Cognitive Impairment\",\n",
      "        \"Depression in Parkinson's Patients\",\n",
      "        \"Drug-Drug Interactions\",\n",
      "        \"Hyponatremia Risk\",\n",
      "        \"Geriatric Depression\",\n",
      "        \"SSRIs for Depression in and Treatment of Multiple Sclerosis\",\n",
      "        \"SSRIs and Bariatric Surgery\"\n",
      "      ],\n",
      "      \"OtherSpecialPop\": [\n",
      "        \"Post-Stroke SSRI Use\",\n",
      "        \"Depression and Cardiovascular Pathology\",\n",
      "        \"Depression in Diabetes\",\n",
      "        \"Depression in Epileptic Patients\",\n",
      "        \"Depression in Hepatitis Patients\",\n",
      "        \"SSRIs for Depression after Traumatic Brain Injury\",\n",
      "        \"SSRIs for Depression in Cancer\",\n",
      "        \"SSRIs for Depression in Kidney Disease Patients\",\n",
      "        \"SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients\",\n",
      "        \"SSRIs for Depression in HIV-positive Patients\",\n",
      "        \"SSRIs for Congenital Myasthenic Syndrome (SCCMS)\"\n",
      "      ]\n",
      "    },\n",
      "    \"OtherIndications\": []\n",
      "  },\n",
      "  \"Safety\": {\n",
      "    \"Prenatal Exposure\": [\n",
      "      \"Prenatal Exposure\",\n",
      "      \"Prenatal Exposure\"\n",
      "    ],\n",
      "    \"Pregnancy\": [\n",
      "      \"Prenatal Exposure\"\n",
      "    ],\n",
      "    \"Suicide\": [\n",
      "      \"Pediatric Depression\",\n",
      "      \"Suicide Risk\"\n",
      "    ],\n",
      "    \"Sexual Dysfunction\": [\n",
      "      \"Sexual Dysfunction\",\n",
      "      \"Treatment of Paroxetine Induced Sexual Dysfunction\",\n",
      "      \"Psilocybin for Depression\"\n",
      "    ],\n",
      "    \"Toxicity\": [\n",
      "      \"Serotonin Syndrome\",\n",
      "      \"Hepatotoxic Risk\"\n",
      "    ],\n",
      "    \"Bleeding Risk\": [\n",
      "      \"Bleeding Risk\"\n",
      "    ],\n",
      "    \"Cardiovascular\": [\n",
      "      \"QTC Prolongation\"\n",
      "    ],\n",
      "    \"OtherSafety\": [\n",
      "      \"Fracture Risk\",\n",
      "      \"Extrapyramidal Reactions Risk\",\n",
      "      \"Oncopreventive and Oncolytic Properties of SSRIs\",\n",
      "      \"Drug-Drug Interactions\",\n",
      "      \"Hyponatremia Risk\",\n",
      "      \"Forensic Drug Concentration\",\n",
      "      \"SSRI Safety Reviews\",\n",
      "      \"Withdrawal Symptoms\",\n",
      "      \"Hyperprolactinemia-related Symptoms\",\n",
      "      \"SRRIs Ocular Safety Risk\",\n",
      "      \"Orofacial Pain Disorders\",\n",
      "      \"Generic SSRIs\",\n",
      "      \"Risk of Hallucinations\",\n",
      "      \"Risk of Microscopic Colitis\",\n",
      "      \"Risk of Reversible Rerebral Vasoconstriction Syndrome (RCVS)\"\n",
      "    ]\n",
      "  },\n",
      "  \"OtherRoot\": {\n",
      "    \"Drugs\": {\n",
      "      \"Paroxetine\": [\n",
      "        \"Paroxetine Binding\",\n",
      "        \"Paroxetine\",\n",
      "        \"Treatment of Paroxetine Induced Sexual Dysfunction\"\n",
      "      ],\n",
      "      \"Fluoxetine\": [\n",
      "        \"Fluoxetine\",\n",
      "        \"Adulterants in Weight Loss Supplements\"\n",
      "      ],\n",
      "      \"Fluoxamine\": [\n",
      "        \"Fluvoxamine for Depression\"\n",
      "      ],\n",
      "      \"Escitalopram\": [\n",
      "        \"Escitalopram for Depression\"\n",
      "      ],\n",
      "      \"Sertraline\": [\n",
      "        \"Sertraline for Depression\",\n",
      "        \"Sertraline\"\n",
      "      ],\n",
      "      \"Agomelatine\": [\n",
      "        \"Agomelatine for Depression\"\n",
      "      ],\n",
      "      \"Vilazodone\": [\n",
      "        \"Vilazodone for Depression\"\n",
      "      ],\n",
      "      \"Psilocybin\": [\n",
      "        \"Methylphenidate augmentation in late-life depression\"\n",
      "      ]\n",
      "    },\n",
      "    \"Ecotoxicology\": [\n",
      "      \"Aquatic Ecotoxicology\",\n",
      "      \"Wastewater Management\"\n",
      "    ],\n",
      "    \"Alternative Treatments\": [\n",
      "      \"Herbal and Natural Compounds for Depression, using Forced Swimming Test\",\n",
      "      \"Herbal and Natural Compounds for Depression\"\n",
      "    ],\n",
      "    \"Drug Utilization Patterns\": [\n",
      "      \"SSRI Utilization Patterns\",\n",
      "      \"Generic SSRIs\"\n",
      "    ],\n",
      "    \"Cost-Effectineness\": [\n",
      "      \"Cost-Effectiveness\"\n",
      "    ],\n",
      "    \"Other\": [\n",
      "      \"Personality Disorder; Learning; Behavioral Effects; Introception\",\n",
      "      \"SSRI Use\",\n",
      "      \"Canine Behavioral Disorders\",\n",
      "      \"Gatways to Clinical Trials\",\n",
      "      \"Behavioral Addictions\",\n",
      "      \"Selective Serotonin Reuptake Inhibitors\",\n",
      "      \"Adulterants in Weight Loss Supplements\",\n",
      "      \"Critical Psychiatry\",\n",
      "      \"SSRIs for Depersonalization Disorder\",\n",
      "      \"Serotonin Modulation Effects on Primates and Rodents\",\n",
      "      \"Risk of Reversible Rerebral Vasoconstriction Syndrome (RCVS)\",\n",
      "      \"Gateways to Clinical Trials\",\n",
      "      \"Citalopram Effect on Indoleamine Metabolism in Maturing Mouse Brains\",\n",
      "      \"Depressed Infertile Women\",\n",
      "      \"SSRIs for Olfactory reference syndrome (ORS)\"\n",
      "    ]\n",
      "  }\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "# Define a function to replace numbers with labels\n",
    "def replace_numbers_with_labels(node, mapping):\n",
    "    if isinstance(node, list):\n",
    "        return [mapping.get(item, item) for item in node]\n",
    "    elif isinstance(node, dict):\n",
    "        return {key: replace_numbers_with_labels(value, mapping) for key, value in node.items()}\n",
    "    else:\n",
    "        return node\n",
    "\n",
    "# Replace numbers with labels in the hierarchy\n",
    "updated_tree_hierarchy = replace_numbers_with_labels(tree_hierarchy, cluster_label_dict)\n",
    "\n",
    "# Print the updated hierarchy to verify the changes\n",
    "print(json.dumps(updated_tree_hierarchy, indent=2))\n",
    "\n",
    "# save as json \n",
    "with open(p + 'FullClusterLabelTree.json', 'w') as f:\n",
    "    json.dump(updated_tree_hierarchy, f, indent=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "from graphviz import Digraph\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "ename": "TypeError",
     "evalue": "plot_hierarchy() got an unexpected keyword argument 'dpi'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[26], line 99\u001b[0m\n\u001b[1;32m     97\u001b[0m \u001b[38;5;66;03m# Plot the hierarchy with a specified size\u001b[39;00m\n\u001b[1;32m     98\u001b[0m dot \u001b[38;5;241m=\u001b[39m plot_hierarchy(tree_hierarchy, width\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m100\u001b[39m\u001b[38;5;124m\"\u001b[39m, height\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m800\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[0;32m---> 99\u001b[0m dot \u001b[38;5;241m=\u001b[39m plot_hierarchy(tree_hierarchy, width\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m10\u001b[39m\u001b[38;5;124m\"\u001b[39m, height\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m8\u001b[39m\u001b[38;5;124m\"\u001b[39m, dpi\u001b[38;5;241m=\u001b[39m\u001b[38;5;241m300\u001b[39m)\n",
      "\u001b[0;31mTypeError\u001b[0m: plot_hierarchy() got an unexpected keyword argument 'dpi'"
     ]
    }
   ],
   "source": [
    "import json\n",
    "from graphviz import Digraph\n",
    "\n",
    "# Function to create a graph from the hierarchy\n",
    "def add_nodes_edges(graph, hierarchy, parent=None):\n",
    "    for key, value in hierarchy.items():\n",
    "        # Create a node for the current key\n",
    "        graph.node(key)\n",
    "        # Add an edge from the parent to the current node\n",
    "        if parent:\n",
    "            graph.edge(parent, key)\n",
    "        # If the value is a dict, recurse\n",
    "        if isinstance(value, dict):\n",
    "            add_nodes_edges(graph, value, key)\n",
    "        # If the value is a list, add the items as nodes\n",
    "        elif isinstance(value, list):\n",
    "            for item in value:\n",
    "                graph.node(item)\n",
    "                graph.edge(key, item)\n",
    "\n",
    "# Function to plot the hierarchy with adjustable figure size\n",
    "def plot_hierarchy(hierarchy, width=\"8\", height=\"6\"):\n",
    "    dot = Digraph(graph_attr={\"size\": f\"{width},{height}\"})\n",
    "    add_nodes_edges(dot, hierarchy)\n",
    "    return dot\n",
    "\n",
    "# Example JSON hierarchy\n",
    "json_string = \"\"\"\n",
    "{\n",
    "  \"Pharmacology\": {\n",
    "    \"Pharmacodynamics\": {\n",
    "      \"Mechanism of action\": [\"Label_A\", \"Label_C\", \"Label_X\", \"Label_Y\", \"Label_Z\"], \n",
    "      \"Animal Models of Disorders\": [\"Label_M\", \"Label_N\", \"Label_O\", \"Label_P\", \"Label_Q\"],\n",
    "      \"Other\": [\"Label_B\", \"Label_D\", \"Label_E\", \"Label_F\", \"Label_G\", \"Label_H\", \"Label_I\", \"Label_J\"]\n",
    "    },\n",
    "    \"Pharmacokinetics\": [\"Label_K\", \"Label_L\"],\n",
    "    \"Pharmacogenetics\": [\"Label_R\", \"Label_S\"],\n",
    "    \"Analytical Methods\": [\"Label_T\", \"Label_U\"],\n",
    "    \"Biomarker Search\": [\"Label_V\", \"Label_W\"],\n",
    "    \"Other\": [\"Label_A\", \"Label_V\", \"Label_60\", \"Label_72\", \"Label_118\"]\n",
    "  },\n",
    "  \"Indications\": {\n",
    "    \"Disorders\": {\n",
    "      \"Depression\": [\n",
    "        \"Label_7\", \"Label_8\", \"Label_12\", \"Label_13\", \"Label_14\", \"Label_17\", \"Label_21\", \"Label_25\", \"Label_41\", \"Label_48\", \"Label_54\", \"Label_55\", \"Label_58\", \"Label_64\", \"Label_74\", \"Label_79\", \"Label_81\", \"Label_82\",\n",
    "        \"Label_86\", \"Label_87\", \"Label_88\", \"Label_93\", \"Label_95\", \"Label_98\", \"Label_100\", \"Label_102\", \"Label_113\", \"Label_115\", \"Label_116\", \"Label_119\", \"Label_120\", \"Label_121\", \"Label_122\",\n",
    "        \"Label_125\", \"Label_128\", \"Label_132\", \"Label_138\", \"Label_141\", \"Label_142\", \"Label_23\", \"Label_47\", \"Label_19\", \"Label_41\"\n",
    "      ],\n",
    "      \"Anxiety\": [\"Label_32\", \"Label_37\", \"Label_63\", \"Label_75\"],\n",
    "      \"OCD\": [\"Label_4\", \"Label_137\", \"Label_139\"],\n",
    "      \"Weight and Eating Disorders\": [\"Label_29\", \"Label_50\"],\n",
    "      \"Substance Abuse\": [\"Label_51\", \"Label_124\"], \n",
    "      \"Other\": [\n",
    "        \"Label_15\", \"Label_22\", \"Label_34\", \"Label_36\", \"Label_42\", \"Label_43\", \"Label_45\", \"Label_52\", \"Label_56\", \"Label_61\", \"Label_62\", \"Label_71\", \"Label_78\", \"Label_91\", \"Label_99\", \"Label_101\", \"Label_103\",\n",
    "        \"Label_104\", \"Label_105\", \"Label_109\", \"Label_110\", \"Label_114\", \"Label_115\", \"Label_123\", \"Label_126\", \"Label_127\", \"Label_129\", \"Label_133\", \"Label_144\"\n",
    "      ]\n",
    "    },\n",
    "    \"Special Populations\": {\n",
    "      \"Pediatrics\": [\"Label_7\", \"Label_56\", \"Label_75\", \"Label_139\"],\n",
    "      \"Geriatrics\": [\"Label_26\", \"Label_38\", \"Label_49\", \"Label_58\", \"Label_65\", \"Label_69\", \"Label_79\", \"Label_115\", \"Label_141\"],\n",
    "      \"Other\": [\"Label_20\", \"Label_21\", \"Label_48\", \"Label_55\", \"Label_87\", \"Label_88\", \"Label_93\", \"Label_100\", \"Label_116\", \"Label_121\", \"Label_131\"]\n",
    "    },\n",
    "    \"Other\": []\n",
    "  },\n",
    "  \"Safety\": {\n",
    "    \"Prenatal Exposure\": [\"Label_2\", \"Label_11\"],\n",
    "    \"Pregnancy\": [\"Label_2\"],\n",
    "    \"Suicide\": [\"Label_7\", \"Label_1\"],\n",
    "    \"Sexual Dysfunction\": [\"Label_0\", \"Label_140\", \"Label_143\"],\n",
    "    \"Toxicity\": [\"Label_18\", \"Label_59\"],\n",
    "    \"Bleeding Risk\": [\"Label_27\"],\n",
    "    \"Cardiovascular\": [\"Label_46\"],\n",
    "    \"Other\": [\"Label_38\", \"Label_40\", \"Label_44\", \"Label_65\", \"Label_69\", \"Label_73\", \"Label_76\", \"Label_80\", \"Label_90\", \"Label_97\", \"Label_99\", \"Label_130\", \"Label_135\", \"Label_147\"]\n",
    "  },\n",
    "  \"Other\": {\n",
    "    \"Drugs\": {\n",
    "      \"Paroxetine\": [\"Label_9\", \"Label_33\", \"Label_140\"],\n",
    "      \"Fluoxetine\": [\"Label_39\", \"Label_134\"],\n",
    "      \"Fluoxamine\": [\"Label_14\"],\n",
    "      \"Escitalopram\": [\"Label_25\"],\n",
    "      \"Sertraline\": [\"Label_64\", \"Label_85\"],\n",
    "      \"Agomelatine\": [\"Label_81\"],\n",
    "      \"Vilazodone\": [\"Label_86\"],\n",
    "      \"Psilocybin\": [\"Label_142\"]\n",
    "    },\n",
    "    \"Ecotoxicology\": [\"Label_1\", \"Label_83\"],\n",
    "    \"Alternative Treatments\": [\"Label_8\", \"Label_35\"],\n",
    "    \"Drug Utilization Patterns\": [\"Label_24\"],\n",
    "    \"Cost-Effectiveness\": [\"Label_31\"],\n",
    "    \"Other\": [\"Label_53\", \"Label_94\", \"Label_96\", \"Label_105\", \"Label_111\", \"Label_134\", \"Label_136\", \"Label_145\", \"Label_147\"]\n",
    "  }\n",
    "}\n",
    "\"\"\"\n",
    "\n",
    "tree_hierarchy = json.loads(json_string)\n",
    "\n",
    "# Plot the hierarchy with a specified size\n",
    "dot = plot_hierarchy(tree_hierarchy, width=\"100\", height=\"800\")\n",
    "dot = plot_hierarchy(tree_hierarchy, width=\"10\", height=\"8\", dpi=300)\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Study1Analysis",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
